Search Results
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Search for other papers by Daniela Pierannunzio in
Google Scholar
PubMed
Search for other papers by Silvia Francisci in
Google Scholar
PubMed
Search for other papers by Angela De Paoli in
Google Scholar
PubMed
Search for other papers by Federica Toffolutti in
Google Scholar
PubMed
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Search for other papers by Silvia Franceschi in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
Search for other papers by of the DEPTH Working Group in
Google Scholar
PubMed
Introduction Radioactive iodine (RAI) treatment may be used after total thyroidectomy (TT) for thyroid cancer for several purposes: remnant ablation to facilitate detection of recurrent disease, adjuvant treatment of subclinical residual tumor
Search for other papers by Lucie Allard in
Google Scholar
PubMed
Search for other papers by Jérôme Alexandre Denis in
Google Scholar
PubMed
Search for other papers by Gaëlle Godiris Petit in
Google Scholar
PubMed
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Elise Mathy in
Google Scholar
PubMed
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
successfully, total thyroidectomy and central and right lymph node dissection were performed. During surgery, the subhyoid muscles and right internal jugular vein had to be excised due to cancer invasion, but the tumor was easily removed from the pharyngeal
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan
Search for other papers by Takaaki Konishi in
Google Scholar
PubMed
Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Michimasa Fujiogi in
Google Scholar
PubMed
Search for other papers by Nobuaki Michihata in
Google Scholar
PubMed
Search for other papers by Takayoshi Niwa in
Google Scholar
PubMed
Department of Health Services, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
Search for other papers by Kojiro Morita in
Google Scholar
PubMed
Search for other papers by Hiroki Matsui in
Google Scholar
PubMed
Search for other papers by Kiyohide Fushimi in
Google Scholar
PubMed
Search for other papers by Masahiko Tanabe in
Google Scholar
PubMed
Search for other papers by Yasuyuki Seto in
Google Scholar
PubMed
Search for other papers by Hideo Yasunaga in
Google Scholar
PubMed
Introduction Thyroidectomy is the only radical treatment for thyroid cancer. Several complications may occur following thyroidectomy: for example, post-operative bleeding, recurrent laryngeal nerve (RLN) paralysis, post-operative hypocalcaemia
Search for other papers by Ian D Hay in
Google Scholar
PubMed
Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed
Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed
are convinced that at our institution, radioiodine remnant ablation (RRA), when administered after potentially curative bilateral thyroidectomy (BT) to low-risk (MACIS scores <6) adult PTC (APTC) patients, has not reduced ( 7 ) either cause
Search for other papers by Inês Damásio in
Google Scholar
PubMed
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Sara Donato in
Google Scholar
PubMed
Search for other papers by Mariana Horta in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Search for other papers by Miguel Rito in
Google Scholar
PubMed
Search for other papers by Pedro Gomes in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
( Fig. 1D ). At this point, ATC was considered surgically resectable, and the patient underwent total thyroidectomy plus central lymphadenectomy. Histological analysis ( Fig. 2B and C ) revealed the presence of residual foci of ATC with tracheal
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
which may be biased in many respects. Nowadays, whenever available we should rely on prospective studies which are feasible, as demonstrated by several trials ( 4 , 5 , 6 , 7 ). Definition of RAI therapy After total thyroidectomy, radioactive
Search for other papers by Diana Borges Duarte in
Google Scholar
PubMed
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Guilherme Assunção in
Google Scholar
PubMed
Search for other papers by André Couto Carvalho in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
patient. Electronic Health Registry and Primary Care data were used to determine the causes of death. Papillary thyroid cancer treatment and follow-up All patients underwent surgical treatment (total thyroidectomy or totalization of previous sub
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
-escalation guideline update in 2016. The ATA management guidelines for adult patients with thyroid nodules and thyroid cancer includes the use of total thyroidectomy (TTX), with or without RAI, and lobectomy for the treatment of thyroid cancers ( 1 ). However, the ATA
Search for other papers by Adile Begüm Bahçecioğlu in
Google Scholar
PubMed
Search for other papers by Alptekin Gürsoy in
Google Scholar
PubMed
Search for other papers by Serpil Dizbay Sak in
Google Scholar
PubMed
Search for other papers by Seyfettin Ilgan in
Google Scholar
PubMed
Search for other papers by Banu Bilezikçi in
Google Scholar
PubMed
Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
the patients were female. Mean age of patients was 38.3 ± 10.2. Surgical procedures were total thyroidectomy and central lymph node dissection (CLND) in 75 (66%), total thyroidectomy central and right LND in 13 (11%), lobectomy and ipsilateral CLND in
Search for other papers by Nianting Ju in
Google Scholar
PubMed
Search for other papers by Liying Hou in
Google Scholar
PubMed
Search for other papers by Hongjun Song in
Google Scholar
PubMed
Search for other papers by Zhongling Qiu in
Google Scholar
PubMed
Search for other papers by Yang Wang in
Google Scholar
PubMed
Search for other papers by Zhenkui Sun in
Google Scholar
PubMed
Search for other papers by Quanyong Luo in
Google Scholar
PubMed
Search for other papers by Chentian Shen in
Google Scholar
PubMed
considered to be a significant treatment for eliminating the remnant thyroid tissue after thyroidectomy, which can increase the specificity of detectable serum thyroglobulin (Tg) as a tumor marker and potentially improve the quality of future 131 I whole